Secreted mucins and airway bacterial colonization in non‐CF bronchiectasis
- 14 July 2015
- journal article
- research article
- Published by Wiley in Respirology
- Vol. 20 (7) , 1082-1088
Abstract
Background and objective: Secreted mucins play a key role in antibacterial defence in the airway, but have not previously been characterized in non‐cystic fibrosis (CF) bronchiectasis patients. We aim to investigate the relationship between secreted mucins levels and the presence of bacterial colonization due to potentially pathogenic microorganisms (PPM) in the airways of stable bronchiectasis patients.Methods: Clinically stable bronchiectasis patients were studied prospectively at two centres. Patients with other pulmonary conditions were excluded. Spontaneous sputum was subject to bacterial culture, and secreted mucins (MUC2, MUC5AC and MUC5B) were measured in sputum supernatants by ELISA.Results: A total of 50 patients were included. PPM were identified from sputum samples in 30 (60%), with Pseudomonas aeruginosa (n = 10) and Haemophilus influenzae (n = 10) as the most common PPM. There were no baseline differences among airway colonized and non‐colonized patients. Patients with airways colonized by PPM presented higher levels of airway MUC2. No differences in MUC5AC levels were found among groups, whereas MUC5B levels were undetectable. Patients with P. aeruginosa colonization expressed the highest levels of MUC2. High levels of MUC2 and MUC5AC are also correlated with disease severity using the Bronchiectasis Severity Index.Conclusions: Airway MUC2 levels were higher in bronchiectasis patients colonized with PPM compared with those without airway colonization, especially in patients with P. aeruginosa. These findings suggest that airway‐secreted mucins levels may play a role in the pathogenesis of airway infection in non‐CF bronchiectasis.Keywords
Funding Information
- Sociedad Española de Neumología (SEPAR)
- Fundacio Catalana de Pneumologia (FUCAP)
- Tenovus Scotland
- National Heart, Lung, and Blood Institute (K23HL096054)
This publication has 30 references indexed in Scilit:
- Mechanisms of immune dysfunction and bacterial persistence in non-cystic fibrosis bronchiectasisMolecular Immunology, 2013
- NF-κB Mediates IL-1β– and IL-17A–Induced MUC5B Expression in Airway Epithelial CellsAmerican Journal of Respiratory Cell and Molecular Biology, 2011
- British Thoracic Society guideline for non-CFbronchiectasisThorax, 2010
- Mortality in bronchiectasis: a long-term study assessing the factors influencing survivalEuropean Respiratory Journal, 2009
- MUC5B Is the Major Mucin in the Gel Phase of Sputum in Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2008
- Structure and Function of the Polymeric Mucins in Airways MucusAnnual Review of Physiology, 2008
- Mucosal inflammation in idiopathic bronchiectasis: cellular and molecular mechanismsEuropean Respiratory Journal, 2008
- Respiratory Tract Mucin Genes and Mucin Glycoproteins in Health and DiseasePhysiological Reviews, 2006
- Bacterial colonisation in patients with bronchiectasis: microbiological pattern and risk factorsThorax, 2002
- Proteinases of Pseudomonas aeruginosa evoke mucin release by tracheal epithelium.Journal of Clinical Investigation, 1984